Beta Drugs Ltd (BETA) Stock Price & News

BETA:NSE

Beta Drugs Ltd

₹2,055.00

+0.10%

(+2.00) 1D

Oct 1, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for BETA...

Open

₹2,030.00

High

₹2,088.50

Low

₹2,020.00

Mkt. cap

22.78B

Avg. vol.

19.50K

Volume

8.70K

P/E ratio

46.49

52-wk high

₹2,807.90

52-wk low

₹990.10

EPS

₹44.20

No. of employees

455

Open

₹2,030.00

High

₹2,088.50

Low

₹2,020.00

Mkt. cap

22.78B

Avg. vol.

19.50K

Volume

8.70K

P/E ratio

46.49

52-wk high

₹2,807.90

52-wk low

₹990.10

EPS

₹44.20

No. of employees

455

Related stocks

DCAL

Dishman Carbogen Amcis Ltd

Shukra Pharmaceuticals Ltd

₹61.97

-0.11%

News stories

From web sources and news partners

The Motley Fool

2 hours ago

History Says Coca-Cola Stock Holds Up When the S&P 500 Falls

MSN

6 hours ago

The S&P 500 is not enough: My 3-stock starter portfolio for new investors

TradingView

7 hours ago

Energy sector outperforms S&P 500 in Q3 as oil prices rise

BigGo Finance

14 hours ago

Hang Seng Tech Tumbles Nearly 40% in a Year While Nasdaq Keeps Hitting Records — Why the Same AI Cycle Produced Divergent Paths

About Beta Drugs Ltd

CEO-

Employees455

Founded1985

Headquarters-

SectorPharmaceutical industry

Websitebetadrugslimited.com

All values in INR	Jun 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.00B	872.68M	939.65M	1.26B
Cost of goods sold	497.43M	360.44M	417.74M	545.16M
Cost of revenue	497.43M	360.44M	417.74M	545.16M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	160.23M	168.23M	237.57M	203.96M
Operating expense	344.85M	386.27M	393.09M	480.11M
Total operating expenses	842.28M	746.71M	810.84M	1.03B
Operating income	159.79M	125.97M	128.81M	230.22M
Other non operating income	29.88M	23.10M	-72.55M	15.83M
EBT including unusual items	156.47M	104.72M	118.31M	220.42M
EBT excluding unusual items	156.47M	104.72M	118.31M	220.42M
Income tax expense	39.48M	19.55M	27.83M	55.56M
Effective tax rate	25.23%	18.67%	23.52%	25.21%
Other operating expenses	147.36M	174.15M	107.55M	232.69M
Net income	116.99M	85.17M	90.49M	158.02M
Net profit margin	11.67%	9.76%	9.63%	12.59%
Earnings per share	-	-	-	-
Interest and investment income	-	-	98.60M	-
Interest expense	-33.20M	-44.34M	-36.55M	-25.63M
Net interest expenses	-33.20M	-44.34M	62.05M	-25.63M
Depreciation and amortization charges	37.26M	43.89M	47.97M	43.46M
EBITDA	188.23M	154.40M	167.33M	273.10M
Gain or loss from assets sale	-	-	-	-

Ask anything